PTC Therapeutics Inc (PTCT)
40.41
-0.06
(-0.15%)
USD |
NASDAQ |
Nov 04, 16:00
40.40
-0.02
(-0.04%)
After-Hours: 20:00
PTC Therapeutics Gross Profit Margin (Quarterly): 91.68% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 91.68% |
| March 31, 2024 | 92.98% |
| December 31, 2023 | 90.52% |
| September 30, 2023 | 95.17% |
| June 30, 2023 | 94.05% |
| March 31, 2023 | 93.58% |
| December 31, 2022 | 93.49% |
| September 30, 2022 | 93.55% |
| June 30, 2022 | 94.18% |
| March 31, 2022 | 93.19% |
| December 31, 2021 | 94.36% |
| September 30, 2021 | 95.29% |
| June 30, 2021 | 93.69% |
| March 31, 2021 | 92.28% |
| December 31, 2020 | 95.89% |
| Date | Value |
|---|---|
| September 30, 2020 | 96.06% |
| June 30, 2020 | 92.95% |
| March 31, 2020 | 94.02% |
| December 31, 2019 | 96.33% |
| September 30, 2019 | 95.79% |
| June 30, 2019 | 96.25% |
| March 31, 2019 | 95.57% |
| December 31, 2018 | 95.64% |
| September 30, 2018 | 93.86% |
| June 30, 2018 | 96.26% |
| March 31, 2018 | 94.57% |
| December 31, 2017 | 96.88% |
| September 30, 2017 | 96.22% |
| June 30, 2017 | 98.42% |
| March 31, 2017 | 99.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
90.52%
Minimum
Dec 2023
96.33%
Maximum
Dec 2019
93.86%
Average
93.69%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 70.27% |
| Vertex Pharmaceuticals Inc | 85.94% |
| BridgeBio Pharma Inc | 72.42% |
| Cassava Sciences Inc | -- |
| Crinetics Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -29.24% |
| Profit Margin (Quarterly) | -53.12% |
| Operating Margin (Quarterly) | -17.87% |
| Return on Net Operating Assets | -56.83% |